Stock ANRO ALTO NEUROSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Alto Neuroscience, Inc.

Equities

ANRO

US02157Q1094

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-20 pm EDT 		5-day change 1st Jan Change
12.4 USD -0.56% Intraday chart for Alto Neuroscience, Inc. -11.99% 0.00%
May. 14 Alto Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 23 Alto Neuroscience, Inc. Announces Positive Phase 1 Results for ALTO-101, A Novel PDE4 Inhibitor in Development for Schizophrenia CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ANRO Stock
  4. Revisions Alto Neuroscience, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW